Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Attovia Therapeutics, Inc. (ATTO) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Attovia Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 2058707.
Total stock buying since 2026: $52,369,979.
Total stock sales since 2026: $4,630,748.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 3,040,587 | $52,369,979 | 211,614 | $4,630,748 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-08 | 3,040,587 | $52,369,979 | 211,614 | $4,630,748 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-08-06 | Wsls Emp Onshore Investments, L.p. (Other) | Buy | 500,000 | 17.00 | 8,500,000 |
| 2026-08-06 | Fhmls Xi, L.l.c. | Buy | 588,235 | 17.00 | 9,999,995 |
| 2026-08-06 | Walsh Colin (Director) | Buy | 500,000 | 17.00 | 8,500,000 |
| 2026-08-06 | Venbio Global Strategic Fund Iv, L.p. | Buy | 382,352 | 17.00 | 6,499,984 |
| 2026-08-06 | Redmile Biopharma Investments Iii, L.p. | Buy | 600,000 | 17.00 | 10,200,000 |
| 2026-08-06 | Sanofi | Buy | 300,000 | 17.00 | 5,100,000 |
| 2026-08-05 | Wsls Emp Onshore Investments, L.p. (Other) | Buy | 85,000 | 21.00 | 1,785,000 |
| 2026-08-05 | Wsls Emp Onshore Investments, L.p. (Other) | Sale | 105,807 | 21.88 | 2,315,374 |
| 2026-08-05 | Walsh Colin (Director) | Buy | 85,000 | 21.00 | 1,785,000 |
| 2026-08-05 | Walsh Colin (Director) | Sale | 105,807 | 21.88 | 2,315,374 |
Insider trading activities including stock purchases, stock sales, and option exercises of ATTO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Attovia Therapeutics, Inc. (symbol ATTO, CIK number 2058707) see the Securities and Exchange Commission (SEC) website.